How COVID-19 could usher in a new role for continuous glucose monitoring in hospitals

Continuous Glucose Monitors (CGMs) were designed for remote patient monitoring at home. However, hospitals have been using CGMs for patients with diabetes during the COVID-19 pandemic to help manage their glucose levels while maintaining social distancing. 

Why it matters: CGMs have not been approved by the FDA for use in hospitals but they have proven useful during the pandemic. CGMs help to manage glucose levels and help to increase people’s time in range. There is not enough data on CGM use in hospitals for FDA approval, but the pandemic provides an opportunity to prove the merit of CGM use in hospitals.